These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 63774)

  • 1. Gabergic compounds and schizophrenia.
    van den Berg CJ
    Lancet; 1976 Dec; 2(7998):1301-2. PubMed ID: 63774
    [No Abstract]   [Full Text] [Related]  

  • 2. Valproate and GABAergic system effects.
    Winterer G
    Neuropsychopharmacology; 2003 Nov; 28(11):2050-1. PubMed ID: 14574363
    [No Abstract]   [Full Text] [Related]  

  • 3. Epigenetic targets in GABAergic neurons to treat schizophrenia.
    Costa E; Dong E; Grayson DR; Ruzicka WB; Simonini MV; Veldic M; Guidotti A
    Adv Pharmacol; 2006; 54():95-117. PubMed ID: 17175812
    [No Abstract]   [Full Text] [Related]  

  • 4. Valproic acid induces manifestations of simultaneous dopamine enhancement and reduction in schizophrenia.
    Lopez LM; Wassef AA; Molloy MS; Williams NG
    Neuropsychopharmacology; 2004 Jun; 29(6):1217; author reply 1218-20. PubMed ID: 15154001
    [No Abstract]   [Full Text] [Related]  

  • 5. gamma-Aminobutyric-acid deficiency in schizophrenia.
    Koran LM
    Lancet; 1976 Nov; 2(7993):1025. PubMed ID: 62243
    [No Abstract]   [Full Text] [Related]  

  • 6. The interaction between GABA and dopamine: implications for schizophrenia.
    Garbutt JC; van Kammen DP
    Schizophr Bull; 1983; 9(3):336-53. PubMed ID: 6137869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sodium valproate and baclofen in tardive dyskinesia: clinical and neuroendocrine studies.
    Nair NP; Lal S; Schwartz G; Thavundayil JX
    Adv Biochem Psychopharmacol; 1980; 24():437-41. PubMed ID: 6773303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia: instability in norepinephrine, serotonin, and gamma-aminobutyric acid systems.
    Gelernter J; van Kammen DP
    Int Rev Neurobiol; 1988; 29():309-47. PubMed ID: 3042667
    [No Abstract]   [Full Text] [Related]  

  • 9. [The neuroprotective effect of GABA-ergic substances in cerebral ischemia].
    Kulinskiĭ VI; Mikhel'son GV
    Eksp Klin Farmakol; 1997; 60(1):56-8. PubMed ID: 9162288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA and movement disorders.
    Marsden CD; Sheehy MP
    Adv Biochem Psychopharmacol; 1981; 30():225-34. PubMed ID: 6460427
    [No Abstract]   [Full Text] [Related]  

  • 11. Epigenetic downregulation of GABAergic function in schizophrenia: potential for pharmacological intervention?
    Costa E; Grayson DR; Guidotti A
    Mol Interv; 2003 Jun; 3(4):220-9. PubMed ID: 14993449
    [No Abstract]   [Full Text] [Related]  

  • 12. Clozapine, GABA(B), and the treatment of resistant schizophrenia.
    Daskalakis ZJ; George TP
    Clin Pharmacol Ther; 2009 Oct; 86(4):442-6. PubMed ID: 19626000
    [No Abstract]   [Full Text] [Related]  

  • 13. [The contribution of drug research to the understanding of schizophrenia].
    Carlsson VA
    Wien Med Wochenschr; 1975 May; 125(21):308-17. PubMed ID: 3029
    [No Abstract]   [Full Text] [Related]  

  • 14. Baclofen in chronic schizophrenia.
    Bigelow LB
    Psychopharmacol Bull; 1977 Jan; 13(1):4-5. PubMed ID: 319473
    [No Abstract]   [Full Text] [Related]  

  • 15. Blepharospasm--successful treatment with baclofen and sodium valproate. A case report.
    Sandyk R
    S Afr Med J; 1983 Dec; 64(24):955-6. PubMed ID: 6417803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a combination of sodium valproate and baclofen in Meige's disease (idiopathic orofacial dystonia).
    Brennan MJ; Ruff P; Sandyk R
    Br Med J (Clin Res Ed); 1982 Sep; 285(6345):853. PubMed ID: 6811040
    [No Abstract]   [Full Text] [Related]  

  • 17. Baclofen in the treatment of tardive dyskinesia and schizophrenia.
    Simpson GM; Lee JH; Shrivastava RK; Branchey MH
    Psychopharmacol Bull; 1978 Apr; 14(2):16-8. PubMed ID: 349598
    [No Abstract]   [Full Text] [Related]  

  • 18. Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population.
    Sharma RP; Rosen C; Kartan S; Guidotti A; Costa E; Grayson DR; Chase K
    Schizophr Res; 2006 Dec; 88(1-3):227-31. PubMed ID: 16996718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of GABAergic drugs on ethanol-induced gastric lesions.
    de Bernardis E; Caruso A; Cutuli VM; Lucenti A; Villari L; Amico-Roxas M
    J Physiol Paris; 1993; 87(6):389-92. PubMed ID: 8292990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroleptic effect of baclofen in chronic schizophrenia (author's transl)].
    Kuhn R
    Arzneimittelforschung; 1976; 26(6):1187. PubMed ID: 989412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.